Literature DB >> 18726071

Differential regulation of collagen types I and III expression in cardiac fibroblasts by AGEs through TRB3/MAPK signaling pathway.

M Tang1, M Zhong, Y Shang, H Lin, J Deng, H Jiang, H Lu, Y Zhang, W Zhang.   

Abstract

Advanced glycation end products (AGEs) play an important role in collagen deposition in diabetic cardiomyopathy. TRB3, a mammalian homolog of Drosophila tribbles, functions to increase glucose intolerance and regulates cell proliferation. We demonstrated that AGEs induce collagen type I expression but inhibit collagen type III expression, accompanied by increased TRB3 expression. Furthermore, the collagen type I induced byAGEs was down-regulated after inhibition of ERK and p38-MAPK, the collagen type III reduced by AGEs was up-regulated after inhibition of ERK. The expression of collagen types I and III regulated by AGEs through MAPK was partly reversed after treatment with TRB3 siRNA. It suggests that the TRB3/MAPK signaling pathway participates in the regulation of collagen types I and III by AGEs and may provide new therapeutic strategies for diabetic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18726071     DOI: 10.1007/s00018-008-8255-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  30 in total

1.  TRB3: an oxidant stress-induced pseudokinase with a potential to negatively modulate MCP-1 cytokine in diabetic nephropathy.

Authors:  Yashpal S Kanwar
Journal:  Am J Physiol Renal Physiol       Date:  2010-08-25

2.  Recovery from volumetric muscle loss injury: A comparison between young and aged rats.

Authors:  John T Kim; Benjamin M Kasukonis; Lemuel A Brown; Tyrone A Washington; Jeffrey C Wolchok
Journal:  Exp Gerontol       Date:  2016-07-17       Impact factor: 4.032

Review 3.  Crosstalk between the renin-angiotensin system and the advance glycation end product axis in the heart: role of the cardiac fibroblast.

Authors:  Katrina Go Yamazaki; Eileen Gonzalez; Alexander C Zambon
Journal:  J Cardiovasc Transl Res       Date:  2012-09-29       Impact factor: 4.132

4.  Advanced glycation end products promote proliferation of cardiac fibroblasts by upregulation of KCa3.1 channels.

Authors:  Li-Mei Zhao; Wei Zhang; Li-Ping Wang; Gui-Rong Li; Xiu-Ling Deng
Journal:  Pflugers Arch       Date:  2012-10-02       Impact factor: 3.657

5.  Effects of linagliptin and liraglutide on glucose- and angiotensin II-induced collagen formation and cytoskeleton degradation in cardiac fibroblasts in vitro.

Authors:  Xian-Wei Wang; Fen-Xi Zhang; Fen Yang; Zu-Feng Ding; Nidhi Agarwal; Zhi-Kun Guo; Jawahar L Mehta
Journal:  Acta Pharmacol Sin       Date:  2016-08-08       Impact factor: 6.150

6.  Type III collagen modulates fracture callus bone formation and early remodeling.

Authors:  Emily L Miedel; Becky K Brisson; Todd Hamilton; Hadley Gleason; Gary P Swain; Luke Lopas; Derek Dopkin; Joseph E Perosky; Kenneth M Kozloff; Kurt D Hankenson; Susan W Volk
Journal:  J Orthop Res       Date:  2015-03-08       Impact factor: 3.494

7.  Sildenafil and FDP-Sr attenuate diabetic cardiomyopathy by suppressing abnormal expression of myocardial CASQ2, FKBP12.6, and SERCA2a in rats.

Authors:  Yu-si Cheng; De-zai Dai; Hui Ji; Qi Zhang; Yin Dai
Journal:  Acta Pharmacol Sin       Date:  2011-03-28       Impact factor: 6.150

8.  Mammalian Tribbles homolog 3 impairs insulin action in skeletal muscle: role in glucose-induced insulin resistance.

Authors:  Jiarong Liu; Xuxia Wu; John L Franklin; Joseph L Messina; Helliner S Hill; Douglas R Moellering; R Grace Walton; Mitchell Martin; W Timothy Garvey
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-12-08       Impact factor: 4.310

9.  TRB3 is stimulated in diabetic kidneys, regulated by the ER stress marker CHOP, and is a suppressor of podocyte MCP-1.

Authors:  Elizabeth Morse; Jana Schroth; Young-Hyun You; Donald P Pizzo; Shinichi Okada; Satish Ramachandrarao; Volker Vallon; Kumar Sharma; Robyn Cunard
Journal:  Am J Physiol Renal Physiol       Date:  2010-07-21

10.  TRB3 gene silencing alleviates diabetic cardiomyopathy in a type 2 diabetic rat model.

Authors:  Yun Ti; Guo-lu Xie; Zhi-hao Wang; Xiao-lei Bi; Wen-yuan Ding; Jia Wang; Gui-Hua Jiang; Pei-Li Bu; Yun Zhang; Ming Zhong; Wei Zhang
Journal:  Diabetes       Date:  2011-09-20       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.